Intuitive Surgical Reports Q1 2026 Earnings Call Summary
Intuitive Surgical reported a 17% total procedure growth in Q1 2026, driven by the adoption of its da Vinci and Ion platforms. International procedures now account for 38% of total volume, and the company raised its full-year 2026 procedure growth guidance to 13.5%–15.5%. The company also highlighted margin strength and strategic investments in digital and AI initiatives.
Tickers: $ISRG
Topics: Earnings Call Financial Performance International Expansion Margin Analysis Procedure Growth Product Launch Regulatory Clearance